Skip to content

Clinical trials

Phase 2 Liver Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20121
20131
20151
20161
20171
20192
20201
20212
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mirum Pharmaceuticals, Inc.3
Gilead Sciences2
AusperBio Therapeutics Inc.1
Bristol-Myers Squibb1
Enyo Pharma1
European Foundation for Study of Chronic Liver Failure1
Genfit1
Imperial College London1
Inventiva Pharma1
Lantheus Medical Imaging1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases15
Non-alcoholic Fatty Liver Disease5
Digestive System Diseases4
Hepatitis3
Acute-On-Chronic Liver Failure2
Bile Duct Diseases2
Biliary Tract Diseases2
Fatty Liver2
Fibrosis2
Hepatitis B, Chronic2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.